Acousort

Acousort Financial Leverage

The Financial Leverage (Equity Multiplier) of Acousort (ACOU.ST) as of Nov 2, 2026 is 1.10. In the previous year, Financial Leverage (Equity Multiplier) was 1.46 — a change of -24.62% (lower).

Financial Leverage

1.10

YoY

-24.62%

Last updated:

Financial Leverage (Equity Multiplier) of Acousort is 2025 1.10 . Financial Leverage (Equity Multiplier) of Acousort was 2024 1.46 . It decreases by -24.62% lower compared to the previous year.

The Acousort Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.12 SEK
Jan 1, 2019
1.36 SEK
Jan 1, 2020
1.37 SEK
Jan 1, 2021
1.11 SEK
Jan 1, 2022
2.12 SEK
Jan 1, 2023
1.43 SEK
Jan 1, 2024
1.46 SEK
Jan 1, 2025
1.10 SEK
The Acousort Financial Leverage history
YEARFinancial LeverageYoY
1.10-24.62%
1.46+1.83%
1.43-32.57%
2.12+91.55%
1.11-19.37%
1.37+1.20%
1.36+21.21%
1.12-12.14%
1.27+5.35%
1.21-63.53%
3.32+35.67%
2.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acousort Stock analysis

What does Acousort do? AcouSort AB develops and sells standalone laboratory products like AcouWash and AcouTrap for cell, bacteria, and extracellular vesicle research, focusing on separation, washing, and enrichment using ultrasound. The company also provides integrated original equipment manufacturer (OEM) solutions and offers custom-developed acoustophoresis applications. Its target customers include research and diagnostic institutions seeking advanced cell separation technologies. The firm generates revenue through the sale of its proprietary laboratory equipment and OEM solutions, with products such as AcouWash and AcouTrap targeting cell, bacteria, and extracellular vesicle research applications. AcouSort AB develops bioanalytical and clinical applications based on acoustophoresis, which are sold to research and diagnostic markets. The company’s offerings are designed for scientific and medical research environments requiring precise biological particle separation. Acousort is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acousort stock

Financial Leverage (Equity Multiplier) of Acousort is 1.10 in 2025.

Financial Leverage (Equity Multiplier) of Acousort changed from 1.46 to 1.10, representing a -24.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Acousort since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Acousort with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Acousort

All Key Metrics — Acousort